Back to Search Start Over

Salivary metabolome indicates a shift in tyrosine metabolism in patients with burning mouth syndrome: a prospective case–control study

Authors :
Charlotte Moreau
Chakib El Habnouni
Jean-Claude Lecron
Franck Morel
Adriana Delwail
Christelle Le Gall-Ianotto
Raphaele Le Garrec
Laurent Misery
Eric Piver
Loïc Vaillant
Antoine Lefevre
Patrick Emond
Hélène Blasco
Mahtab Samimi
Université de Tours (UT)
Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)
Service Immunologie/Inflammation [CHU Poitiers]
Centre hospitalier universitaire de Poitiers (CHU Poitiers)
Laboratoire Inflammation, Tissus épithéliaux et Cytokines (LITEC)
Université de Poitiers
ImageUP (Plateforme d'Imagerie de l'Université de Poitiers)
Signalisation et Transports Ioniques Membranaires (STIM)
Université de Poitiers-Université de Tours (UT)-Centre National de la Recherche Scientifique (CNRS)
Laboratoire sur les interactions Epithéliums Neurones (LIEN)
Université de Brest (UBO)
Imagerie et cerveau (iBrain - Inserm U1253 - UNIV Tours )
Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Service de Médecine Nucléaire [Tours]
CHU Trousseau [APHP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Infectiologie et Santé Publique (UMR ISP)
Université de Tours (UT)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
Chanteloup, Nathalie Katy
Source :
PAIN, PAIN, 2022, 164 (3), pp.e144-e156. ⟨10.1097/j.pain.0000000000002733⟩
Publication Year :
2022
Publisher :
HAL CCSD, 2022.

Abstract

International audience; The pathophysiology of primary burning mouth syndrome (BMS) remains controversial. Targeted analyses or "omics" approach of saliva provide diagnostic or pathophysiological biomarkers. This pilot study's primary objective was to explore the pathophysiology of BMS through a comparative analysis of the salivary metabolome among 26 BMS female cases and 25 age- and sex-matched control subjects. Secondary objectives included comparative analyses of inflammatory cytokines, neuroinflammatory markers, and steroid hormones among cases and control subjects, and among BMS patients according to their clinical characteristics. Salivary metabolome, neuroinflammatory markers, cytokines, and steroids were, respectively, analysed by liquid chromatography coupled with mass spectrometry, ELISA and protease activity assay, and multiparametric Luminex method. Among the 166 detected metabolites, univariate analysis did not find any discriminant metabolite between groups. Supervised multivariate analysis divided patients into 2 groups with an accuracy of 60% but did not allow significant discrimination (permutation test, P = 0.35). Among the metabolites contributing to the model, 3 belonging to the tyrosine pathway ( l -dopa, l -tyrosine, and tyramine) were involved in the discrimination between cases and control subjects, and among BMS patients according to their levels of pain. Among the detectable molecules, levels of cytokines, steroid hormones, and neuroinflammatory markers did not differ between cases and control subjects and were not associated with characteristics of BMS patients. These results do not support the involvement of steroid hormones, inflammatory cytokines, or inflammatory neurogenic mediators in the pathophysiology of pain in BMS, whereas the observed shift in tyrosine metabolism may indicate an adaptative response to chronic pain or an impaired dopaminergic transmission.

Details

Language :
English
ISSN :
03043959 and 18726623
Database :
OpenAIRE
Journal :
PAIN, PAIN, 2022, 164 (3), pp.e144-e156. ⟨10.1097/j.pain.0000000000002733⟩
Accession number :
edsair.doi.dedup.....51f46af5795a6bdbdfe3b1e4a577c790